Standardization of HbA1c measurements--a consensus statement.
about
Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetesContinuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetesContinuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetesGlycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of european prospective investigation of cancer and nutrition (EPIC-Norfolk)Glycated haemoglobin, diabetes, and mortality in men. Maybe disturbance in physiological mechanisms regulating blood glucose is risk factor for cardiovascular deathSelf-monitoring of glucose levels for people with type 2 diabetes.A matrix-assisted laser desorption/ionization mass spectrometry study of the non-enzymatic glycation products of human globins in diabetes.Glycosylated hemoglobin and the risk of death and cardiovascular mortality in the elderlyManagement of gestational diabetes mellitus.What should we measure in the diabetic patient and how does this respond to therapy?Considerations on blood glucose management in Type 2 diabetes mellitus.Diabetes services in the UK: third national survey confirms continuing deficiencies.Diabetes control and complications: the role of glycated haemoglobin, 25 years on.Association between HbA1c and carotid atherosclerosis among elderly Koreans with normal fasting glucosePlatelet volume indices as predictive biomarkers for diabetic complications in Type 2 diabetic patients.Novel metabolic biomarkers of cardiovascular disease.The incidence of type 2 diabetes in the United Kingdom from 1991 to 2010.Prevalence, glucose control and relative survival of people with Type 2 diabetes in the UK from 1991 to 2013.HbA1c measurement.Glycated haemoglobin assays. Approaches to standardization of results.Standardization of glycated haemoglobin.Initiation of insulin glargine therapy in type 2 diabetes subjects suboptimally controlled on oral antidiabetic agents: results from the AT.LANTUS trial.
P2860
Q24244108-601D7469-9616-4DFA-99EB-8C9A13753F2DQ24246012-5C4FFCF3-E80E-41ED-B736-10C0E803C8CFQ26471516-7157C8FA-8661-4094-8487-A851DA8A50A8Q28345602-3EAC40EF-CD1B-4BD3-B21E-A6BC54C43D48Q28364397-BC4DB557-DAD5-429E-9B12-61DDE974E399Q31037192-FD498D84-8117-4A84-8D06-AF2107889AFCQ31135569-66827669-206A-417C-987A-7B233A2F5920Q33923697-EDF3A7E8-5269-485B-B6B9-3CDAE5CD18ECQ34620699-6FC8D9FF-2FF2-41E5-843F-E26EFB046B57Q34722753-D64346B4-7F16-4C0E-A8C4-F637A3A3172DQ34804238-7978DFFA-6621-4E65-985A-D24BC8D43825Q35273676-77F07779-90CE-458C-AB25-CDA6B26B3039Q35812833-D29A10D8-F237-43E2-BD7F-3E407BEAC35FQ36274187-A4DFECFE-C860-4B92-A564-CF79101B43D2Q37658715-03E88ABF-B175-4CAE-94D7-F83F1BA75B4EQ38245327-E2DDF9DF-3035-4477-AF70-BB3CBECDB0B8Q38426346-C779C172-592F-4ACC-8504-1469273AC544Q40345956-1BE16C97-355F-4BC8-8B0F-05DAA0465A86Q43010782-01E98499-A402-4DF3-9162-B5C8266CE8E6Q43662169-5C1D7C10-96B7-4487-864D-69BEC9280FC2Q44004505-0B6EC8D8-1F5F-4B04-89D6-FD2D51217A09Q46691040-A245E6AB-51C4-4E50-A680-4B3F12DB6693
P2860
Standardization of HbA1c measurements--a consensus statement.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Standardization of HbA1c measurements--a consensus statement.
@ast
Standardization of HbA1c measurements--a consensus statement.
@en
type
label
Standardization of HbA1c measurements--a consensus statement.
@ast
Standardization of HbA1c measurements--a consensus statement.
@en
prefLabel
Standardization of HbA1c measurements--a consensus statement.
@ast
Standardization of HbA1c measurements--a consensus statement.
@en
P1433
P1476
Standardization of HbA1c measurements--a consensus statement.
@en
P2093
P2860
P356
10.1046/J.1464-5491.2000.00228.X
P577
2000-01-01T00:00:00Z